Form 4: PROCEPT BioRobotics CEO Reza Zadno Reports Stock and Option Transactions
SEC Form 4 Filing
CEO Reza Zadno reports acquisition and disposal of common stock and acquisition of stock options in PROCEPT BioRobotics Corp.
Summary
- Reza Zadno, CEO of PROCEPT BioRobotics Corp, filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2025, Zadno acquired 41,699 shares of common stock and disposed of 194,461 shares.
- Zadno also acquired stock options for 36,831 shares with an exercise price of $60.60, expiring on March 2, 2035.
- The stock options vest monthly from March 5, 2025, over four years.
- The reported transactions leave Zadno with 194,461 shares of common stock and 36,831 stock options.
- The filing was signed by Jonathan Stone, Attorney-in-Fact for Reza Zadno, on March 5, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- Shareholders are informed about the CEO's transactions in company stock, which can influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of common stock acquisition and disposal, and stock option acquisition. |
| 03/05/2025 | Date of filing by Attorney-in-Fact. |
| 03/05/2025 | Vesting commencement date for stock options. |
| 03/02/2035 | Expiration date for stock options. |
| 03/05/2026 | Date of first vesting of restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.